Payment overview · 2025
General Payments
$560.34
11 reported records · 4 companies
Healthcare provider profile · identity verified
Thomas L. Michalsen, D.O.
Allopathic & Osteopathic Physicians|General Practice · KIRKLAND, IL · NPI 1114947876
Verified facts
What the public records show
CMS Open Payments records show Thomas L. Michalsen, D.O. received $560.34 in general payments during 2025 across 11 reported records.
AstraZeneca Pharmaceuticals LP accounted for 59.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga, Mounjaro.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 53 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 129 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 34 claims for Symbicort by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 402 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 320 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 217 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $333.83 | 59.6% | 3 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $164.34 | 29.3% | 6 | 2025 |
| Cipher Pharmaceuticals US LLC | Unresolved — no canonical attribution shown | $43.08 | 7.7% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $19.09 | 3.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $560.34 | 11 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $219.99 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $113.56 | 3 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $99.99 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $64.34 | 5 | 2025 |
Source payment records
|
|||||
| Natroba Normalized: natroba |
Drug | Cipher Pharmaceuticals US LLC | $43.08 | 1 | 2025 |
Source payment records
|
|||||
| Spinosad Normalized: spinosad |
Drug | Cipher Pharmaceuticals US LLC | $43.08 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $19.09 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 129 | exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 320 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
53 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
129 | 26 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
34 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
402 | 43 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
320 | 59 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
217 | 27 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 2556 | 296 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2270 | 250 |
| Gabapentin | Gabapentin | 2250 | 226 |
| Atorvastatin Calcium | Atorvastatin Calcium | 2150 | 224 |
| Amlodipine Besylate | Amlodipine Besylate | 1803 | 239 |
| Potassium Chloride | Potassium Chloride | 1755 | 198 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1588 | 315 |
| Quetiapine Fumarate | Quetiapine Fumarate | 1480 | 182 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1422 | 215 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1412 | 191 |
| Lisinopril | Lisinopril | 1316 | 163 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1215 | 164 |
| Famotidine | Famotidine | 1134 | 70 |
| Eliquis | Apixaban | 1087 | 119 |
| Metformin Hcl | Metformin Hcl | 1074 | 127 |
| Olanzapine | Olanzapine | 965 | 57 |
| Donepezil Hcl | Donepezil Hcl | 924 | 97 |
| Escitalopram Oxalate | Escitalopram Oxalate | 878 | 118 |
| Metoprolol Succinate | Metoprolol Succinate | 878 | 138 |
| Omeprazole | Omeprazole | 868 | 124 |
| Sertraline Hcl | Sertraline Hcl | 833 | 100 |
| Xarelto | Rivaroxaban | 820 | 79 |
| Clopidogrel | Clopidogrel Bisulfate | 790 | 89 |
| Mirtazapine | Mirtazapine | 771 | 79 |
| Losartan Potassium | Losartan Potassium | 767 | 146 |
| Levetiracetam | Levetiracetam | 750 | 55 |
| Carvedilol | Carvedilol | 702 | 91 |
| Trazodone Hcl | Trazodone Hcl | 701 | 72 |
| Memantine Hcl | Memantine Hcl | 605 | 72 |
| Spironolactone | Spironolactone | 553 | 92 |
| Meloxicam | Meloxicam | 529 | 68 |
| Irbesartan | Irbesartan | 476 | 125 |
| Benztropine Mesylate | Benztropine Mesylate | 473 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 471 | 73 |
| Glipizide | Glipizide | 437 | 35 |
| Finasteride | Finasteride | 430 | 81 |
| Atenolol | Atenolol | 429 | 40 |
| Risperidone | Risperidone | 414 | 33 |
| Jardiance | Empagliflozin | 402 | 43 |
| Buspirone Hcl | Buspirone Hcl | 397 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 391 | 46 |
| Ropinirole Hcl | Ropinirole Hcl | 339 | 37 |
| Prednisone | Prednisone | 336 | 113 |
| Hydralazine Hcl | Hydralazine Hcl | 322 | 39 |
| Mounjaro | Tirzepatide | 320 | 59 |
| Allopurinol | Allopurinol | 319 | 56 |
| Bumetanide | Bumetanide | 315 | 37 |
| Divalproex Sodium | Divalproex Sodium | 314 | 35 |
| Ezetimibe | Ezetimibe | 297 | 69 |
| Midodrine Hcl | Midodrine Hcl | 286 | 37 |
| Bupropion Xl | Bupropion Hcl | 284 | 48 |
| Aripiprazole | Aripiprazole | 280 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 260 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 260 | 51 |
| Simvastatin | Simvastatin | 259 | 15 |
| Montelukast Sodium | Montelukast Sodium | 255 | 51 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 251 | 65 |
| Cilostazol | Cilostazol | 250 | 27 |
| Tramadol Hcl | Tramadol Hcl | 250 | 74 |
| Methenamine Hippurate | Methenamine Hippurate | 249 | 36 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 242 | 32 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 241 | 27 |
| Aptiom | Eslicarbazepine Acetate | 240 | 12 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 237 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 233 | 27 |
| Dicyclomine Hcl | Dicyclomine Hcl | 230 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 227 | 73 |
| Trulicity | Dulaglutide | 217 | 27 |
| Warfarin Sodium | Warfarin Sodium | 215 | 26 |
| Propranolol Hcl | Propranolol Hcl | 212 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 206 | 32 |
| Gemtesa | Vibegron | 179 | 14 |
| Clonidine Hcl | Clonidine Hcl | 173 | 14 |
| Verapamil Er | Verapamil Hcl | 173 | 42 |
| Amitriptyline Hcl | Amitriptyline Hcl | 171 | 19 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 162 | 35 |
| Azithromycin | Azithromycin | 157 | 114 |
| Memantine Hcl Er | Memantine Hcl | 157 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 153 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 152 | 77 |
| Doxazosin Mesylate | Doxazosin Mesylate | 150 | 34 |
| Glimepiride | Glimepiride | 147 | 36 |
| Verapamil Sr | Verapamil Hcl | 146 | 28 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 145 | 37 |
| Baclofen | Baclofen | 143 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 143 | 50 |
| Citalopram Hbr | Citalopram Hydrobromide | 141 | 20 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 141 | 18 |
| Divalproex Sodium Er | Divalproex Sodium | 141 | 15 |
| Latanoprost | Latanoprost | 140 | 35 |
| Myrbetriq | Mirabegron | 140 | 23 |
| Alprazolam | Alprazolam | 138 | 40 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 137 | 31 |
| Levofloxacin | Levofloxacin | 135 | 108 |
| Alendronate Sodium | Alendronate Sodium | 134 | 25 |
| Cephalexin | Cephalexin | 134 | 96 |
| Farxiga | Dapagliflozin Propanediol | 129 | 26 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 128 | suppressed |
| Ozempic | Semaglutide | 126 | 21 |
| Januvia | Sitagliptin Phosphate | 122 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 122 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 115 | 42 |
| Nabumetone | Nabumetone | 115 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 111 | 28 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 110 | 23 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 106 | 55 |
| Haloperidol | Haloperidol | 102 | 18 |
| Oxcarbazepine | Oxcarbazepine | 101 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 99 | 12 |
| Calcitriol | Calcitriol | 99 | 11 |
| Torsemide | Torsemide | 96 | 11 |
| Rivastigmine | Rivastigmine Tartrate | 95 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 94 | 31 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 94 | 67 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 94 | 58 |
| Entresto | Sacubitril/Valsartan | 90 | 11 |
| Clonazepam | Clonazepam | 89 | 27 |
| Prazosin Hcl | Prazosin Hcl | 89 | suppressed |
| Valsartan | Valsartan | 88 | 27 |
| Topiramate | Topiramate | 87 | 17 |
| Meclizine Hcl | Meclizine Hcl | 85 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 84 | suppressed |
| Lamotrigine | Lamotrigine | 82 | 13 |
| Rivastigmine | Rivastigmine | 81 | 16 |
| Calcium Acetate | Calcium Acetate | 80 | suppressed |
| Celecoxib | Celecoxib | 76 | 29 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 76 | suppressed |
| Digoxin | Digoxin | 73 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 73 | 26 |
| Novolog Flexpen | Insulin Aspart | 73 | 19 |
| Humalog Kwikpen U-100 | Insulin Lispro | 72 | 23 |
| Ziprasidone Hcl | Ziprasidone Hcl | 72 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 70 | 13 |
| Nystatin | Nystatin | 70 | 45 |
| Fenofibrate | Fenofibrate,micronized | 69 | suppressed |
| Lubiprostone | Lubiprostone | 69 | suppressed |
| Metolazone | Metolazone | 69 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 68 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 68 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 67 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 67 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 67 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 67 | 16 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 63 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 63 | suppressed |
| Lorazepam | Lorazepam | 61 | 27 |
| Nateglinide | Nateglinide | 61 | 16 |
| Primidone | Primidone | 61 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 60 | 39 |
| Doxycycline Hyclate | Doxycycline Hyclate | 60 | 47 |
| Fenofibrate | Fenofibrate | 60 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 58 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 57 | suppressed |
| Mupirocin | Mupirocin | 57 | 31 |
| Bupropion Hcl | Bupropion Hcl | 56 | suppressed |
| Lactulose | Lactulose | 56 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 56 | suppressed |
| Nystop | Nystatin | 56 | 26 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 54 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 54 | 14 |
| Fluconazole | Fluconazole | 54 | 32 |
| Nebivolol Hcl | Nebivolol Hcl | 54 | 17 |
| Brilinta | Ticagrelor | 53 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 53 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 52 | suppressed |
| Ibuprofen | Ibuprofen | 52 | 16 |
| Lithium Carbonate | Lithium Carbonate | 52 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 52 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 51 | 42 |
| Cholestyramine | Cholestyramine (With Sugar) | 51 | suppressed |
| Nifedipine Er | Nifedipine | 51 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 51 | 29 |
| Acamprosate Calcium | Acamprosate Calcium | 50 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 50 | 43 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 50 | 23 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 50 | 32 |
| Amoxicillin | Amoxicillin | 49 | 38 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 49 | suppressed |
| Linzess | Linaclotide | 49 | 13 |
| Sucralfate | Sucralfate | 49 | suppressed |
| Synthroid | Levothyroxine Sodium | 49 | 13 |
| Nitroglycerin Patch | Nitroglycerin | 46 | 11 |
| Dilt-Xr | Diltiazem Hcl | 45 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 45 | suppressed |
| Carbamazepine | Carbamazepine | 44 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 43 | suppressed |
| Restasis | Cyclosporine | 42 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 41 | suppressed |
| Ingrezza | Valbenazine Tosylate | 40 | suppressed |
| Glipizide Er | Glipizide | 39 | 13 |
| Brimonidine Tartrate | Brimonidine Tartrate | 38 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 38 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 38 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 37 | 15 |
| Niacin Er | Niacin | 37 | 12 |
| Tobramycin Sulfate | Tobramycin Sulfate | 36 | suppressed |
| Acyclovir | Acyclovir | 35 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 35 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 34 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 34 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 33 | suppressed |
| Fentanyl | Fentanyl | 33 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 33 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 33 | 13 |
| Kapspargo Sprinkle | Metoprolol Succinate | 32 | suppressed |
| Ssd | Silver Sulfadiazine | 32 | 13 |
| Santyl | Collagenase Clostridium Hist. | 31 | 17 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 31 | 20 |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 30 | 16 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 30 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 30 | 20 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Anastrozole | Anastrozole | 29 | suppressed |
| Azathioprine | Azathioprine | 29 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 29 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 29 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 29 | 23 |
| Pregabalin | Pregabalin | 29 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 29 | suppressed |
| Trospium Chloride | Trospium Chloride | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | 12 |
| Timolol Maleate | Timolol Maleate | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | 12 |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 27 | 13 |
| Methylprednisolone | Methylprednisolone | 27 | 26 |
| Vancomycin Hcl | Vancomycin Hcl | 27 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 26 | 11 |
| Colestipol Hcl | Colestipol Hcl | 26 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 26 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 26 | suppressed |
| Lacosamide | Lacosamide | 25 | suppressed |
| Cyclosporine | Cyclosporine | 24 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 24 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 24 | suppressed |
| Lumigan | Bimatoprost | 24 | suppressed |
| Metronidazole | Metronidazole | 24 | 19 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 24 | suppressed |
| Xifaxan | Rifaximin | 24 | suppressed |
| Levocarnitine | Levocarnitine | 23 | suppressed |
| Lidocaine | Lidocaine | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Amantadine | Amantadine Hcl | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | suppressed |
| Insulin Lispro | Insulin Lispro | 22 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 22 | 20 |
| Albuterol Sulfate | Albuterol Sulfate | 21 | 15 |
| Alogliptin | Alogliptin Benzoate | 21 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 21 | suppressed |
| Cefdinir | Cefdinir | 21 | 16 |
| Cholestyramine Light | Cholestyramine | 21 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 15 |
| Propranolol Hcl Er | Propranolol Hcl | 21 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 20 | 20 |
| Folic Acid | Folic Acid | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Tobramycin | Tobramycin | 20 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 19 | suppressed |
| Ketoconazole | Ketoconazole | 19 | suppressed |
| Klor-Con | Potassium Chloride | 19 | suppressed |
| Linezolid | Linezolid | 19 | 16 |
| Methimazole | Methimazole | 19 | suppressed |
| Movantik | Naloxegol Oxalate | 19 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 19 | suppressed |
| Telmisartan | Telmisartan | 19 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | 15 |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 18 | suppressed |
| Hydroxyurea | Hydroxyurea | 18 | suppressed |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 17 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 17 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 17 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 17 | suppressed |
| Kerendia | Finerenone | 17 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | 11 |
| Vascepa | Icosapent Ethyl | 17 | suppressed |
| Ertapenem | Ertapenem Sodium | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | 13 |
| Risperidone Odt | Risperidone | 16 | suppressed |
| Abilify Maintena | Aripiprazole | 15 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 15 | 15 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Leflunomide | Leflunomide | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Zocor | Simvastatin | 15 | suppressed |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 14 | 14 |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 14 | suppressed |
| Daptomycin | Daptomycin | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Dulera | Mometasone/Formoterol | 14 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 14 | 14 |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Renacidin | Citric Ac/Gluconolact/Mag Carb | 14 | suppressed |
| Repatha Sureclick | Evolocumab | 14 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 14 | suppressed |
| Captopril | Captopril | 13 | suppressed |
| Dexamethasone | Dexamethasone | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Humira | Adalimumab | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Rhopressa | Netarsudil Mesylate | 12 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 12 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Glatopa | Glatiramer Acetate | 11 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Rebif | Interferon Beta-1a/Albumin | 11 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 11 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 11 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $560.34 · 11 records | AstraZeneca Pharmaceuticals LP | AUSTEDO XR, BREZTRI, FARXIGA, MOUNJARO, Natroba, Spinosad, ZEPBOUND | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error